Sponsored by WuXi AppTec 22 Sep 2021 Discovering New Therapeutic Targets for Alzheimer’s Disease Effective therapies for neurodegenerative diseases like Alzheimer’s are urgently needed. But developing new drugs is difficult, time-consuming, and expensive, with a high risk of failure. Strategic partnerships can help biotech companies manage costs and access the latest technologies to drive innovation and advance novel therapy ideas. A serious unmet medical need Finding treatments for neurodegenerative […] September 22, 2021 - 7 minutesmins - By Julia Kaiser Share WhatsApp Twitter Linkedin Email
News and Trends 21 Sep 2021 Europe’s Antibiotic Investments Stagnate As Resistance Crisis Looms Despite the urgent danger of antibiotic resistance, investments into European biotech antibiotic players have remained flat. However, growing regulatory and societal awareness could spell fresh investments in the coming years. Over the last decade, pressure has been mounting on healthcare systems as infectious microbes become harder and harder to fight with antibiotics. Some strains of […] September 21, 2021 - 7 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Expert Advice 20 Sep 2021 What Makes a Good Chief Financial Officer in the Biotech Industry? A chief financial officer in the life sciences needs to develop their skills beyond technical expertise. Catherine Moukheibir shares her advice for CFOs in biotech drawing from her experience being one and hiring people for that position. Catherine Moukheibir’s career in biotech spans two decades. She has been a chief financial officer (CFO) twice, and […] September 20, 2021 - 8 minutesmins - By Victor Kotsev Share WhatsApp Twitter Linkedin Email
News and Trends 17 Sep 2021 Cell Therapy Firm Raises €64M to Revolutionize Manufacturing This week’s €64M Series B fundraise from the French firm TreeFrog Therapeutics is the latest in a thriving movement to make the manufacture of gene and cell therapies easier and cheaper. Cell and gene therapies offer huge potential to treat a wide range of diseases including cancer, neurological, and genetic diseases. They have even shown […] September 17, 2021 - 8 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 15 Sep 2021 UK Startup Surfs Investment Wave in Microbiome with €18M Series A As increasing attention turns to microbiome-based therapeutics, the Scottish biotech Enterobiotix has closed a Series A fundraising to potentially treat a myriad of medical conditions by improving gut health. Last week, EnteroBiotix raised €18M (£15.5M) in Series A funding to further develop a pill to restore the patient’s gut microbiome to a healthy state using […] September 15, 2021 - 4 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email
In Depth 15 Sep 2021 Blood Cells: The Future of Drug Delivery From red blood cells to platelets, the cells in our own blood could prove an effective way of delivering drugs to their target and improving their safety. Many pharmaceutical drugs in the market come with side effects that generally arise from their effects on parts of the body other than their intended target. Even when […] September 15, 2021 - 7 minutesmins - By Sachin Rawat Share WhatsApp Twitter Linkedin Email
News and Trends 10 Sep 2021 The Top European Biotech Funding Rounds in August UK and German companies led the European biotech funding race in August, specializing in cell therapy, diagnostics, and RNA-based treatments. With summer in full swing, August was a quieter month than July in terms of European biotech funding. Private biotechs in Europe and Israel — in addition to those going public in an initial public […] September 10, 2021 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 8 Sep 2021 As J&J Vaccine Fails Phase II, the Quest for an HIV Vaccine Continues Johnson & Johnson became the latest company to have a failed vaccine trial against HIV last week. While it was a great disappointment to many, efforts continue in this space, helped by recent Covid-19 vaccine advances. HIV has been around for decades. While antiretroviral treatments have improved enormously, turning what was once a death sentence […] September 8, 2021 - 5 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
In Depth 6 Sep 2021 Why We Desperately Need to Develop New Antifungals While serious fungal infections are rare, there is a limited number of approved drugs to treat them, and they may not always work due to the rise of antimicrobial resistance. Despite the challenges, researchers are starting to add new weapons to the arsenal to protect us against these microscopic invaders. Developing effective antifungals is a […] September 6, 2021 - 10 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 2 Sep 2021 AC Immune’s Mixed Phase II Results Buoy Alzheimer’s Research An Alzheimer’s disease drug developed by AC Immune and Genentech has drawn conflicting phase II results this week, raising tentative hopes for the field of treatments targeting the protein tau. For decades, the major culprit responsible for Alzheimer’s disease was suggested to be the buildup of a protein called amyloid-beta in the brain. Blocking this […] September 2, 2021 - 5 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Best in Biotech 2 Sep 2021 The top 15 biotech companies to find in the Netherlands The Netherlands has established itself as a biotech and life sciences hub, possessing leading academic and research institutions and an excellent business infrastructure that makes it an attractive place for biotech companies to grow and thrive. In this article, we take a look at some of the top biotechs in the country. The Netherlands is […] September 2, 2021 - 7 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 1 Sep 2021 Slow-Release Jab for Child Growth Hormone Deficiency Gets FDA Nod The FDA has given the green light to Danish company Ascendis Pharma for the first slow-release formulation that provides a weekly alternative to daily injections for children with growth hormone deficiency. For decades, patients with growth hormone deficiency have required tedious daily hormone injections to stave off the effects of the rare condition, including slow […] September 1, 2021 - 5 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email